Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tyrosine Kinase
100%
TNK2
100%
Triple-negative Breast Cancer
100%
Novel Therapeutic Targets
100%
TNBC Tumor
20%
Tumor Growth
20%
Metastasis
13%
Estrogen Receptor/progesterone Receptor
13%
TNBC Treatment
13%
Pharmacological Inhibitors
13%
Clinical Trials
6%
Small Molecule Inhibitors
6%
Molecular Biology Techniques
6%
Receptor Tyrosine Kinase
6%
ACK1
6%
Effective Treatment
6%
Drug Compounds
6%
Xenograft Tumor Growth
6%
TNBC Cells
6%
Small RNA Interference
6%
Phosphoproteomic Analysis
6%
Poor Prognosis
6%
Protein Kinase
6%
Breast Cancer
6%
Highly Aggressive
6%
Therapeutic Inhibitors
6%
Drug Target
6%
Advanced Mass Spectrometry
6%
Tumor Transplantation
6%
New Drug Targets
6%
Effective Compounds
6%
Immunodeficient Mice
6%
Phosphorylation
6%
Small Molecules
6%
Signaling Pathway
6%
High Risk
6%
Cell Growth
6%
Patient Specimens
6%
Therapeutic Measures
6%
Breast Tumor
6%
Targeted Therapeutics
6%
Dominant Features
6%
Aggressive Tumor
6%
Relapse Risk
6%
Real Potential
6%
HER2-positive
6%
Human Epidermal Growth Factor Receptor 2 (HER2)
6%
Therapeutic Strategies
6%
Mass Spectrometry-based Proteomics
6%
HER2 Receptor
6%
Effective Strategies
6%
Mouse Model
6%
Tumor Specimens
6%
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase
100%
Tyrosine Kinase
100%
Tumor Progression
100%
Small Molecule
50%
Progesterone Receptor
50%
Estrogen Receptor
50%
Proteomics
25%
Protein Kinases
25%
Small RNAs
25%
Mass Spectrometry
25%
RNAI
25%
Mouse Model
25%
Clinical Trial
25%
Molecular Biology
25%
Cell Growth
25%
Animal Model
25%
Phosphoproteomics
25%
phosphorylation
25%
Signal Transduction
25%
Immunology and Microbiology
Phosphotransferase
100%
Kinase
100%
Therapeutic Target
100%
Tyrosine
100%
Cell Line
50%
Signal Transduction
25%
RNAI
25%
Xenograft
25%
Mouse Model
25%
Proteomics
25%
phosphorylation
25%
Cell Growth
25%
Mass Spectrometry
25%